Nomura Holdings
MRNA icon

Nomura Holdings’s Moderna MRNA Stock Holding History

Nomura Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
21,400
-3,600
-14% -$186K ﹤0.01% 1222
2026
Q1 		$1.27M Buy
+25,000
New +$1.17M ﹤0.01% 1077
2025
Q4 		– Sell
-70,000
Closed -$1.81M – 2065
2025
Q3 		$1.81M Sell
70,000
-55,000
-44% -$1.53M ﹤0.01% 1170
2025
Q2 		$3.45M Buy
+125,000
New +$3.29M 0.01% 677
2024
Q3 		– Sell
-260,300
Closed -$30.9M – 1818
2024
Q2 		$30.9M Buy
+260,300
New +$32.9M 0.06% 178
2024
Q1 		– Sell
-2,100
Closed -$209K – 1885
2023
Q4 		$209K Sell
2,100
-23,700
-92% -$1.99M ﹤0.01% 1575
2023
Q3 		$2.66M Sell
25,800
-1,200
-4% -$134K 0.01% 716
2023
Q2 		$3.28M Buy
27,000
+12,000
+80% +$1.6M 0.01% 605
2023
Q1 		$2.3M Buy
+15,000
New +$2.47M 0.01% 775
2022
Q4 		– Sell
-1,200
Closed -$143K – 1612
2022
Q3 		$143K Sell
1,200
-200
-14% -$30.3K ﹤0.01% 1279
2022
Q2 		$209K Hold
1,400
– – ﹤0.01% 1276
2022
Q1 		$248K Buy
1,400
+1,200
+600% +$202K ﹤0.01% 1505
2021
Q4 		$50K Buy
+200
New +$58.5K ﹤0.01% 2065
2020
Q4 		– Sell
-345,000
Closed -$24.4M – 1605
2020
Q3 		$24.4M Buy
+345,000
New +$24.1M 0.05% 203

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Nomura Holdings's MRNA Position: Q2 2026 in Review

Nomura Holdings increased its Moderna (MRNA) stake by 12% in Q2 2026, buying an estimated $253K and bringing the position to 45,437 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Nomura Holdings first reported a position in MRNA in Q3 2019 and has held it in 23 quarters since. The position peaked at $16M in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Nomura Holdings held 45,437 shares of Moderna worth $3.18M as of Q2 2026.
  • Nomura Holdings bought 4,894 Moderna shares in Q2 2026, an estimated $253K.
  • Moderna made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #936 holding.
  • Nomura Holdings first reported a position in Moderna in Q3 2019 and has held it in 23 quarters since.
  • Nomura Holdings's Moderna position peaked at $16M in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.